ONCOCYTE CORP (OCX) Institutional Ownership Changes & 13F Activity
ONCOCYTE CORP (OCX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Broadwood Capital Inc, Awm Investment Company, Inc., Pura Vida Investments, Llc, Geode Capital Management, Llc, and Blackrock, Inc..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Flatrock Wealth Partners Llc | Buy | +13,044 | — | 13,044 | $42.78K | Q4 2025 | May 26, 2026 |
| Broadwood Capital Inc | Buy | +11,410,100 | — | 11,410,100 | $85.58M | Q4 2025 | Feb 17, 2026 |
| 683 Capital Management, Llc | Buy | +77,204 | — | 77,204 | $579.03K | Q4 2025 | Feb 17, 2026 |
| Susquehanna International Group, Llp | Buy | +72,451 | — | 72,451 | $543.38K | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +61,377 | — | 61,377 | $460.33K | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +48,858 | — | 48,858 | $366.44K | Q4 2025 | Feb 17, 2026 |
| Qube Research & Technologies Ltd | Buy | +28,351 | — | 28,351 | $212.63K | Q4 2025 | Feb 17, 2026 |
| Osaic Holdings, Inc. | Buy | +24,136 | — | 24,136 | $181.02K | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +15,647 | — | 15,647 | $117.35K | Q4 2025 | Feb 17, 2026 |
| Private Advisor Group, Llc | Buy | +10,416 | — | 10,416 | $78.12K | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +335 | — | 335 | $2.51K | Q4 2025 | Feb 17, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +250 | — | 250 | $1.88K | Q4 2025 | Feb 17, 2026 |
| Awm Investment Company, Inc. | Buy | +2,814,230 | — | 2,814,230 | $21.11M | Q4 2025 | Feb 13, 2026 |
| Pura Vida Investments, Llc | Buy | +947,134 | — | 947,134 | $7.10M | Q4 2025 | Feb 13, 2026 |
| State Street Corp | Buy | +47,754 | — | 47,754 | $358.15K | Q4 2025 | Feb 13, 2026 |
| Morgan Stanley | Buy | +35,913 | — | 35,913 | $269.35K | Q4 2025 | Feb 13, 2026 |
| Omers Administration Corp | Buy | +26,164 | — | 26,164 | $196.23K | Q4 2025 | Feb 13, 2026 |
| Hudson Bay Capital Management Lp | Buy | +13,061 | — | 13,061 | $97.96K | Q4 2025 | Feb 13, 2026 |
| Citigroup Inc | Buy | +1 | — | 1 | $8.00 | Q4 2025 | Feb 13, 2026 |
| Blackrock, Inc. | Buy | +131,361 | — | 131,361 | $985.21K | Q4 2025 | Feb 12, 2026 |
| Jane Street Group, Llc | Buy | +42,469 | — | 42,469 | $318.52K | Q4 2025 | Feb 12, 2026 |
| Renaissance Technologies LLC | Sell | -10,200 | -43.2% | 13,400 | $100.50K | Q4 2025 | Feb 12, 2026 |
| Jpmorgan Chase & Co | Buy | +154 | — | 154 | $1.16K | Q4 2025 | Feb 11, 2026 |
| Goldman Sachs Group Inc | Buy | +23,965 | — | 23,965 | $179.74K | Q4 2025 | Feb 10, 2026 |
| Bnp Paribas Financial Markets | Buy | +30 | — | 30 | $225.00 | Q4 2025 | Feb 10, 2026 |
| Geode Capital Management, Llc | Buy | +230,971 | — | 230,971 | $1.73M | Q4 2025 | Feb 09, 2026 |
| Eversource Wealth Advisors, Llc | Buy | +5,000 | — | 5,000 | $37.50K | Q4 2025 | Feb 06, 2026 |
| Sbi Securities Co., Ltd. | Buy | +185 | — | 185 | $1.39K | Q4 2025 | Feb 03, 2026 |
| Ubs Group Ag | Buy | +2,941 | — | 2,941 | $22.06K | Q4 2025 | Jan 29, 2026 |
| Albion Financial Group | Buy | +7 | — | 7 | $53.00 | Q4 2025 | Jan 21, 2026 |
Frequently asked questions about OCX activity
Which institutional owners are buying OCX?
Institutional owners buying OCX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in OCX activity?
"Buy" means an investor increased their reported position in OCX compared to the prior reporting period. This reflects growing exposure to ONCOCYTE CORP (OCX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in OCX increasing?
Institutional interest in OCX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related OCX Institutional Insights
- OCX Overview
- OCX 13F Institutional Holders
- OCX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- OCX Insider Trading & SEC Form 4 Activity
- OCX Articles
- Top Institutional Investor Stock Rankings